Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/15/2021 06/16/2021 06/17/2021 06/18/2021 06/21/2021 Date
81.95(c) 81.77(c) 81.15(c) 80.82(c) 81.51 Last
2 286 273 1 911 197 2 668 295 4 311 338 2 042 330 Volume
-0.99% -0.22% -0.76% -0.41% +0.85% Change
More quotes
Financials (USD)
Sales 2021 12 657 M - -
Net income 2021 1 636 M - -
Net Debt 2021 2 243 M - -
P/E ratio 2021 26,6x
Yield 2021 1,27%
Sales 2022 13 307 M - -
Net income 2022 1 931 M - -
Net Debt 2022 1 916 M - -
P/E ratio 2022 21,5x
Yield 2022 1,40%
Capitalization 40 987 M 40 987 M -
EV / Sales 2021 3,42x
EV / Sales 2022 3,22x
Nbr of Employees 50 000
Free-Float 73,4%
More Financials
Company
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition... 
More about the company
Ratings of Baxter International Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about BAXTER INTERNATIONAL INC.
06/16BAXTER INTERNATIONALá : Finding Purpose Through Volunteerism
PU
06/16BAXTER INTERNATIONALá : to Host Second-Quarter 2021 Financial Results Conference..
AQ
06/15BAXTER INTERNATIONALá : to Host Second-Quarter 2021 Financial Results Conference..
BU
06/08BAXTER INTERNATIONALá : Presents Data at 58th ERA-EDTA Congress Indicating Thera..
BU
06/03BAXTER INTERNATIONAL INC. : Ex-dividend day for
FA
06/02BAXTER INTERNATIONALá : Launches the Sharesource Analytics 1.0 Digital Health Mo..
BU
05/25BAXTER INTERNATIONALá : Barclays Starts Baxter International at Equalweight with..
MT
05/25BAXTER INTERNATIONALá : Launches PrisMax 2 System to Advance Critical Care Deliv..
BU
05/11PRESS RELEASE : MIG portfolio company AMSilk completes EUR29 million financing r..
DJ
05/05BAXTER INTERNATIONAL INCá : Submission of Matters to a Vote of Security Holders ..
AQ
05/04BAXTER INTERNATIONALá : to Present at the UBS Global Healthcare Virtual Conferen..
BU
05/04BAXTER INTERNATIONALá : Ups Dividend by 14% to $0.28/Share, Payable on July 1 to..
MT
05/04BAXTER INTERNATIONALá : Board Boosts Quarterly Dividend By 14%
MT
05/03Baxter International Raises Dividend 14%
DJ
05/03BAXTER INTERNATIONALá : Increases Dividend and Declares Quarterly Dividend
BU
More news
News in other languages on BAXTER INTERNATIONAL INC.
04/27DGAP-NEWS : MIG AG verzeichnet 2020 bestes Jahr der Unternehmensgeschichte und s..
03/15HINTERGRUND/Biontech formt globale Allianz für mehr Corona-Impfstoff
03/08MODERNAá : Baxter International va aider à fabriquer le vaccin
02/23Farmacéuticas rivales se unen para fabricar más vacunas de Covid-19
2020EN DIRECT DES MARCHESá : Sanofi, Dassault, Ubisoft, Softbank, Vale, Tesla, Signi..
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | BAX | US0718131099 | MarketScreener
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 93,59 $
Last Close Price 80,82 $
Spread / Highest target 29,9%
Spread / Average Target 15,8%
Spread / Lowest Target -1,01%
EPS Revisions
Managers and Directors
NameTitle
JosÚ E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.0.72%40 640
ABBOTT LABORATORIES0.77%196 037
MEDTRONIC PLC5.20%165 794
BECTON, DICKINSON AND COMPANY-3.87%69 953
HOYA CORPORATION1.26%48 451
ALIGN TECHNOLOGY, INC.12.59%47 612